Authors:
DRAGAN Y
KLAUNIG J
MARONPOT R
GOLDSWORTHY T
Citation: Y. Dragan et al., MEETING OVERVIEW - MECHANISMS OF SUSCEPTIBILITY TO MOUSE-LIVER CARCINOGENESIS, Fundamental and applied toxicology, 41(1), 1998, pp. 3-7
Authors:
LI DH
DRAGAN Y
JORDAN VC
WANG MY
PITOT HC
Citation: Dh. Li et al., EFFECTS OF CHRONIC ADMINISTRATION OF TAMOXIFEN AND TOREMIFENE ON DNA-ADDUCTS IN RAT-LIVER, KIDNEY, AND UTERUS, Cancer research, 57(8), 1997, pp. 1438-1441
Authors:
SARGENT L
DRAGAN Y
XU YH
SATTLER G
WILEY J
PILOT HC
Citation: L. Sargent et al., KARYOTYPIC CHANGES IN A MULTISTAGE MODEL OF CHEMICAL HEPATOCARCINOGENESIS IN THE RAT, Cancer research, 56(13), 1996, pp. 2985-2991
Authors:
DRAGAN Y
TEEGUARDEN J
CAMPBELL H
HSIA S
PITOT H
Citation: Y. Dragan et al., THE QUANTITATION OF ALTERED HEPATIC FOCI DURING MULTISTAGE HEPATOCARCINOGENESIS IN THE RAT - TRANSFORMING GROWTH-FACTOR-ALPHA EXPRESSION ASA MARKER FOR THE STAGE OF PROGRESSION, Cancer letters, 93(1), 1995, pp. 73-83
Authors:
SARGENT L
DRAGAN Y
BAHNUB N
WILEY J
SATTLER C
SCHROEDER P
SATTLER G
JORDAN VC
PITOT H
Citation: L. Sargent et al., TAMOXIFEN INDUCES HEPATIC ANEUPLOIDY AND MITOTIC SPINDLE DISRUPTION AFTER A SINGLE IN-VIVO ADMINISTRATION TO FEMALE SPRAGUE-DAWLEY RATS, Cytogenetics and cell genetics, 69(1-2), 1995, pp. 125-126